| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5700141 | Clinical Oncology | 2010 | 7 Pages |
Abstract
Preoperative cisplatin-based chemotherapy plus radiotherapy is recommended as the preferred modality for the management of surgically resectable patients with oesophageal cancer. Preoperative cisplatin-based chemotherapy alone is an alternative choice for the management of these patients.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
R. Malthaner, R.K.S. Wong, K. Spithoff,